DOI: 10.1055/s-00000054

Pharmacopsychiatry

Issue 03 · Volume 33 · May 2000 DOI: 10.1055/s-002-235

Letter to the Editors

11
González, E.; Minguez, L.; Sanguino, R. M.: Galactorrhea after Paroxetine Treatment

Original Paper

81
Baptista, T.; Lacruz, A.; de Mendoza, S.; MendozaGuillén, J. M.; Silvera, R.; Angeles, F.; Mendoza, M. T.; Hernández, L.: Body Weight Gain after Administration of Antipsychotic Drugs: Correlation with Leptin, Insulin and Reproductive hormones
89
Weyer, G.; Eul, A.; Milde, K.; Wierich, W.; Herrmann, W. M.: Cyclandelate in the Treatment of Patients with Mild to Moderate Primary Degenerative Dementia of the Alzheimer Type or Vascular Dementia: Experience from a Placebo Controlled Multi-center Study
98
Steinert, T.; Sippach, T.; Gebhardt, R. P.: How Common is Violence in Schizophrenia despite Neuroleptic Treatment?
103
Rüther, E.; Glaser, A.: A Prospective PMS Study to Validate the Sensitivity for Change of the D-Scale in Advanced Stages of Dementia Using the NMDA-Antagonist Memantine
109
Kühn, M.; Schuld, A.; Haack, M.; Kraus, T.; Hinze-Selch, D.; Lechner, C.; Pollmächer, T.: A Comparison of the Effects of Clozapine and Olanzapine on the EEG in Patients with Schizophrenia

Case Report

112
Eap, C. B.; Bertel-Laubscher, R.; Zullino, D.; Amey, M.; Baumann, P.: Marked Increase of Venlafaxine Enantiomer Concentrations as a Consequence of Metabolic Interactions: A Case Report
116
Göder, R.; Friege, L.; Treskov, V.; Grohmann, R.; Aldenhoff, J. B.: Association of Paroxetine with Suicide Attempt in Obsessive-Compulsive Disorder